Who owns VERACYTE, INC. (VCYT)? Elite investor 13F holders
3 tracked elite investors reported holding VERACYTE, INC as of 2026-06-30, including D.E. Shaw, Bridgewater Associates, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| D.E. Shaw | VERACYTE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 24257663.00 USD | 413037.000000 | Shares | add | Original filing |
| Renaissance Technologies LLC | VERACYTE INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
| Bridgewater Associates | VERACYTE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3423313.00 USD | 58289.000000 | Shares | reduce | Original filing |
| Gotham Asset Management | VERACYTE INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1370699.00 USD | 23339.000000 | Shares | reduce | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.